Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria

C Rossig, H Juergens, M Schrappe… - Pediatric blood & …, 2013 - Wiley Online Library
Abstract In Germany and Austria, more than 90% of pediatric cancer patients are enrolled
into nationwide disease‐specific first‐line clinical trials or interim registries. Essential …
被引用次数：91 相关文章

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

C Rossig, H Juergens, M Schrappe, A Moericke… - Pediatric Blood & …, 2013 - infona.pl
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease‐specific first‐line clinical trials or interim registries. Essential …
[PDF] psu.edu

[PDF][PDF] Effective Childhood Cancer Treatment: The Impact of Large Scale Clinical Trials in Germany and Austria

C Rossig, H Juergens, M Schrappe, A Moericke… - Pediatr Blood …, 2013 - Citeseer
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …

Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria.

C Rossig, H Juergens, M Schrappe… - Pediatric Blood & …, 2013 - europepmc.org
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …
[PDF] academia.edu

[PDF][PDF] Effective Childhood Cancer Treatment: The Impact of Large Scale Clinical Trials in Germany and Austria

C Rossig, H Juergens, M Schrappe, A Moericke… - Pediatr Blood …, 2013 - academia.edu
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

C Rossig, H Juergens, M Schrappe… - Pediatr. Blood …, 2013 - nbn-resolving.org
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …

Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria

C Rossig, H Juergens, M Schrappe… - Pediatric blood & …, 2013 - pubmed.ncbi.nlm.nih.gov
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

C Rossig, H Juergens, M Schrappe… - Pediatr. Blood …, 2013 - kups.ub.uni-koeln.de
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …
[PDF] academia.edu

[PDF][PDF] Effective Childhood Cancer Treatment: The Impact of Large Scale Clinical Trials in Germany and Austria

C Rossig, H Juergens, M Schrappe, A Moericke… - Pediatr Blood …, 2013 - academia.edu
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …

Effective childhood cancer treatment: The impact of large scale clinical trials in Germany and Austria

C Rossig, H Juergens, M Schrappe… - Pediatr. Blood …, 2013 - kups.ub.uni-koeln.de
In Germany and Austria, more than 90% of pediatric cancer patients are enrolled into
nationwide disease-specific first-line clinical trials or interim registries. Essential components …